Phase 2 IBD Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
Study of DISC-0974-201 in Participants With IBD and Anemia
AnemiaInflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (IBD); Anemia
Disc Medicine, Inc21 enrolled8 locationsNCT07368972
Recruiting
Phase 2
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
Crohn DiseaseUlcerative Colitis (UC)IBD
Assistance Publique - Hôpitaux de Paris45 enrolled1 locationNCT07300553
Recruiting
Phase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Crohn's DiseaseUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Mirador Therapeutics, Inc.140 enrolled66 locationsNCT07113522
Recruiting
Phase 2
Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
Rheumatoid ArthritisIBD
University Medical Center Groningen36 enrolled1 locationNCT03938701
Recruiting
Phase 2
Vancomycin in Primary Sclerosing Cholangitis in Italy
Primary Sclerosing CholangitisIBDLiver and Intrahepatic Bile Duct Disorder
University of Milano Bicocca84 enrolled1 locationNCT05876182
Recruiting
Phase 2Phase 3
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
ColitisIBD (Inflammatory Bowel Disease)Probiotic Intervention
Changhai Hospital120 enrolled1 locationNCT07047339
Recruiting
Phase 2Phase 3
Unravelling Intestinal Fibrosis in Ulcerative Colitis
Fibroblast Activation Protein InhibitorUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10 enrolled1 locationNCT06604273
Recruiting
Phase 2
FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients
IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)Crohn Disease (CD)
Dalia Lartey20 enrolled1 locationNCT06604260